AAAAAA
Results:
1-19
|
Results: 19
Authors:
SCHERNTHANER G
WEIN W
SHNAWA N
SCHWEIGHOFER D
BIRKETT M
Citation: G. Schernthaner et al., PREPRANDIAL VERSUS POSTPRANDIAL INSULIN LISPRO - A COMPARATIVE LONG-TERM CROSSOVER TRIAL IN 30 TYPE-1 DIABETIC-PATIENTS, Diabetologia, 41, 1998, pp. 182-182
Authors:
TOLLEFSON GD
TRAN PV
BIRKETT M
SHOSHANI D
Citation: Gd. Tollefson et al., TREATMENT FAILURE WITH CLOZAPINE - CAN OLANZAPINE BE THE ALTERNATIVE THERAPY, Schizophrenia research, 24(1-2), 1997, pp. 191-191
Authors:
BERK M
DUPLESSIS AD
BIRKETT M
RICHARDT D
Citation: M. Berk et al., AN OPEN-LABEL STUDY OF DULOXETINE HYDROCHLORIDE, A MIXED SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR, IN PATIENTS WITH DSM-III-R MAJOR DEPRESSIVE DISORDER, International clinical psychopharmacology, 12(3), 1997, pp. 137-140
Authors:
TRAN P
SHAMIR E
POYOROVSKI M
LOKSHIN P
WEIZER N
DORFMAN P
MARK M
BIRKETT M
BENASSAYAG E
SHOSHANI D
WIMMER P
DOSSENBACH M
Citation: P. Tran et al., OLANZAPINE IN THE TREATMENT OF PATIENTS WHO FAILED TO RESPOND TO OR TOLERATE CLOZAPINE, Psychopharmacology bulletin, 33(3), 1997, pp. 599-599
Authors:
BLUM WF
ENGLARO P
HANITSCH S
JUUL A
HERTEL NT
MULLER J
SKAKKEBAEK NE
HEIMAN ML
BIRKETT M
ATTANASIO AM
KIESS W
RASCHER W
Citation: Wf. Blum et al., PLASMA LEPTIN LEVELS IN HEALTHY-CHILDREN AND ADOLESCENTS - DEPENDENCEON BODY-MASS INDEX, BODY-FAT MASS, GENDER, PUBERTAL STAGE, AND TESTOSTERONE, The Journal of clinical endocrinology and metabolism, 82(9), 1997, pp. 2904-2910
Authors:
LLEWELYN J
BIRKETT M
BOGGS B
RODER M
BERNE C
PRANGE A
Citation: J. Llewelyn et al., COMPARISON OF THE EFFECT OF USING INSULIN LISPRO WITH ULTRALENTE AND NPH BASAL REGIMENS IN IDDM PATIENTS, Diabetologia, 40, 1997, pp. 1383-1383
Authors:
LLEWELYN J
MARTIN J
BIRKETT M
MICHELS R
RAYMAN G
Citation: J. Llewelyn et al., ACCEPTABILITY OF A PATCH LIKE DEVICE FOR CONTINUOUS BASAL INSULIN SUPPLY, Diabetologia, 40, 1997, pp. 1413-1413
Authors:
SCHERNTHANER G
WEIN W
SANDHOLZER K
EQUILUZBRUCK S
BIRKETT M
Citation: G. Schernthaner et al., POSTPRANDIAL INSULIN LISPRO - A NEW OPTION IN TYPE-I DIABETIC-PATIENTS, Diabetes, 46, 1997, pp. 388-388
Authors:
APTER JT
THASE ME
BIRKETT M
Citation: Jt. Apter et al., FLUOXETINE TREATMENT IN DEPRESSED-PATIENTS WHO FAILED TREATMENT WITH SERTRALINE, Psychopharmacology bulletin, 32(3), 1996, pp. 411-411
Authors:
SCHERNTHANER G
WEIN W
SANDHOLZER K
EQUILUZBRUCK S
BIRKETT M
Citation: G. Schernthaner et al., POSTPRANDIAL USE OF INSULIN LISPRO - A NEW THERAPEUTIC OPTION IN THE TREATMENT OF TYPE-1 DIABETIC-PATIENTS, Diabetologia, 39, 1996, pp. 85-85
Authors:
PANDE AC
BIRKETT M
FECHNERBATES S
HASKETT RF
GREDEN JF
Citation: Ac. Pande et al., FLUOXETINE VERSUS PHENELZINE IN ATYPICAL DEPRESSION, Biological psychiatry, 40(10), 1996, pp. 1017-1020
Authors:
SMALL GW
BIRKETT M
MEYERS BS
KORAN LM
BYSTRITSKY A
NEMEROFF CB
ABUZZAHAB FS
ALEXOPOULOS GS
BIELSKI RJ
BORISON RL
BROD MS
COHENCOLE SA
COHN CK
DOWNS JM
DUPONT RL
FERGUSON JM
FOLKS DG
GOTTLIEB GL
GRABER B
MENOLASCINO FJ
HALARIS AE
HARTFORD JT
HERTZMAN M
JEFFERSON JW
JESTE DV
LAZARUS LW
NAKRA BR
OXENKRUG GF
RAPPAPORT SA
ROSENTHAL MH
SALZMAN C
SHRIVASTAVA RK
STOKES PE
WINSTON JL
WHEADON DW
SCHATZ EJ
MARVEL DE
ALBRITTON R
TOLLEFSON GD
LILLY E
Citation: Gw. Small et al., IMPACT OF PHYSICAL ILLNESS ON QUALITY-OF-LIFE AND ANTIDEPRESSANT RESPONSE IN GERIATRIC MAJOR DEPRESSION, Journal of the American Geriatrics Society, 44(10), 1996, pp. 1220-1225
Authors:
CARA JF
GERTNER J
LINARELLI L
BIRKETT M
CHIPMAN J
Citation: Jf. Cara et al., RECOMBINANT HUMAN (RH) GROWTH-HORMONE (GH) TREATMENT (RX) OF IDIOPATHIC GH DEFICIENCY (IGHD) - EFFECT ON GROWTH, PUBERTAL MATURATION, AND BONE MATURATION, Pediatric research, 37(4), 1995, pp. 3-3
INSULIN IMMUNE-RESPONSE TO LYSPRO HUMAN INSULIN THERAPY IN INSULIN NAIVE TYPE-I AND TYPE-II PATIENTS
Authors:
FINEBERG SE
FINEBERG NS
ANDERSON JH
BIRKETT M
Citation: Se. Fineberg et al., INSULIN IMMUNE-RESPONSE TO LYSPRO HUMAN INSULIN THERAPY IN INSULIN NAIVE TYPE-I AND TYPE-II PATIENTS, Diabetologia, 38, 1995, pp. 4-4
Authors:
FINEBERG SE
FINEBERG NS
ANDERSON JH
BIRKETT M
Citation: Se. Fineberg et al., DOES THE USE OF SHORT-ACTING (LYSPRO) HUMAN INSULIN IN INSULIN NAIVE PATIENTS AUGMENT THE INSULIN IMMUNE-RESPONSE OR DIFFER BETWEEN TYPE-I AND TYPE-II PATIENTS, Diabetes, 44, 1995, pp. 231-231
Authors:
TOLLEFSON GD
BIRKETT M
KORAN L
GENDUSO L
Citation: Gd. Tollefson et al., CONTINUATION TREATMENT OF OCD - DOUBLE-BLIND AND OPEN-LABEL EXPERIENCE WITH FLUOXETINE, The Journal of clinical psychiatry, 55, 1994, pp. 69-78
Authors:
FINEBERG NS
FINEBERG SE
ANDERSON JH
BIRKETT M
GIBSON RG
HUFFERD S
Citation: Ns. Fineberg et al., DOES LYSPRO (B28,29) HUMAN INSULIN ANALOG HAVE ALTERED IMMUNOGENICITYIN PATIENTS WITH TYPE-1 DIABETES, Diabetologia, 37, 1994, pp. 10000167-10000167
Authors:
FINEBERG SE
FINEBERG NS
ANDERSON JH
BIRKETT M
GIBSON RG
HUFFERD S
Citation: Se. Fineberg et al., COMPARATIVE IMMUNOGENICITY OF LYSPRO (B28,29) HUMAN INSULIN ANALOG BETWEEN TYPE-I AND TYPE-II PATIENTS, Diabetologia, 37, 1994, pp. 10000168-10000168
Authors:
WOOD A
TOLLEFSON GD
BIRKETT M
Citation: A. Wood et al., PHARMACOTHERAPY OF OBSESSIVE-COMPULSIVE DISORDER - EXPERIENCE WITH FLUOXETINE, International clinical psychopharmacology, 8(4), 1993, pp. 301-306
Risultati:
1-19
|